Articles with public access mandates - A SchapiraLearn more
Not available anywhere: 11
Review
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities
D Berg, AE Lang, RB Postuma, W Maetzler, G Deuschl, T Gasser, ...
The Lancet Neurology 12 (5), 514-524, 2013
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Review
Monoamine oxidase B inhibitors for the treatment of Parkinson’s disease: a review of symptomatic and potential disease-modifying effects
AHV Schapira
CNS drugs 25, 1061-1071, 2011
Mandates: Parkinson's UK
Review
Long‐term efficacy and safety of safinamide as add‐on therapy in early P arkinson's disease
AHV Schapira, F Stocchi, R Borgohain, M Onofrj, M Bhatt, P Lorenzana, ...
European Journal of Neurology 20 (2), 271-280, 2013
Mandates: National Institute of Health and Medical Research, France
Review
Glucocerebrosidase in Parkinson's disease: insights into pathogenesis and prospects for treatment
AHV Schapira, D Chiasserini, T Beccari, L Parnetti
Movement Disorders 31 (6), 830-835, 2016
Mandates: UK Medical Research Council, National Institute for Health Research, UK …
Review
Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
N Giladi, RN Alcalay, G Cutter, T Gasser, T Gurevich, GU Höglinger, ...
The Lancet Neurology 22 (8), 661-671, 2023
Mandates: US Department of Defense, US National Institutes of Health, German Research …
Review
Early versus delayed initiation of pharmacotherapy in Parkinson’s disease
M Löhle, CJ Ramberg, H Reichmann, AHV Schapira
Drugs 74, 645-657, 2014
Mandates: National Institute for Health Research, UK
Review
The timing of deep brain stimulation for Parkinson disease in the UK from 1997 to 2012
RM DeSouza, H Akram, HL Low, AL Green, K Ashkan, AHV Schapira
European Journal of Neurology 22 (10), 1415-1417, 2015
Mandates: National Institute for Health Research, UK
Review
Early L-dopa, but not pramipexole, restores basal ganglia activity in partially 6-OHDA-lesioned rats
C Marín, M Bonastre, G Mengod, R Cortés, A Giralt, JA Obeso, ...
Neurobiology of disease 64, 36-47, 2014
Mandates: UK Medical Research Council, National Institute for Health Research, UK …
Review
Biofluid biomarkers in Parkinson's disease: clarity amid controversy
SRL Vieira, M Toffoli, P Campbell, AHV Schapira
Movement Disorders 35 (7), 1128-1133, 2020
Mandates: UK Medical Research Council, Parkinson's UK
Review
Prospects for Disease Slowing in Parkinson Disease
E Menozzi, AHV Schapira
Annual Review of Pharmacology and Toxicology 65, 2024
Mandates: UK Medical Research Council, Michael J Fox Foundation
Review
Glucocerebrosidase, a Parkinson´ s disease-associated protein, is imported into mitochondria and regulates complex I assembly and function
P Baden, MJ Perez, S Kalb, H Raji, M Illescas, C Giuliano, F Bertoli, ...
Mandates: Helmholtz Association, European Commission, Government of Spain, Michael J …
Available somewhere: 161
Review
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
Mandates: Swiss National Science Foundation, US National Institutes of Health, US …
Review
Non-motor features of Parkinson disease
AHV Schapira, KR Chaudhuri, P Jenner
Nature Reviews Neuroscience 18 (7), 435-450, 2017
Mandates: UK Medical Research Council, National Institute for Health Research, UK …
Review
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
DG Healy, M Falchi, SS O'Sullivan, V Bonifati, A Durr, S Bressman, ...
The Lancet Neurology 7 (7), 583-590, 2008
Mandates: US National Institutes of Health
Review
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
JA Obeso, M Stamelou, CG Goetz, W Poewe, AE Lang, D Weintraub, ...
Movement disorders 32 (9), 1264-1310, 2017
Mandates: US National Institutes of Health
Review
Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission
L Alvarez-Erviti, Y Seow, AH Schapira, C Gardiner, IL Sargent, MJA Wood, ...
Neurobiology of disease 42 (3), 360-367, 2011
Mandates: Parkinson's UK
Review
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
ME Gegg, D Burke, SJR Heales, JM Cooper, J Hardy, NW Wood, ...
Annals of neurology 72 (3), 455-463, 2012
Mandates: Parkinson's UK
Review
A novel α-synuclein missense mutation in Parkinson disease
C Proukakis, CG Dudzik, T Brier, DS MacKay, JM Cooper, GL Millhauser, ...
Neurology 80 (11), 1062-1064, 2013
Mandates: US National Institutes of Health, Parkinson's UK
Review
Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus
MJ Devine, M Ryten, P Vodicka, AJ Thomson, T Burdon, H Houlden, ...
Nature communications 2 (1), 440, 2011
Mandates: Parkinson's UK
Review
Systemic exosomal siRNA delivery reduced alpha‐synuclein aggregates in brains of transgenic mice
JM Cooper, PBO Wiklander, JZ Nordin, R Al‐Shawi, MJ Wood, M Vithlani, ...
Movement Disorders 29 (12), 1476-1485, 2014
Mandates: Swedish Research Council, UK Medical Research Council, National Institute …
Publication and funding information is determined automatically by a computer program